SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: alexander orlov who wrote (2236)5/8/1998 9:50:00 AM
From: swamp fox  Respond to of 9523
 
Looks like we could have found the bottom yesterday.



To: alexander orlov who wrote (2236)5/8/1998 12:12:00 PM
From: Spunky Beaver  Read Replies (1) | Respond to of 9523
 
I love it! $285M in the first 3 weeks! And the analyst projected $600 million for Calendar 98! My overly optimistic project for Calendar 99 was $10B. That might be too low!



To: alexander orlov who wrote (2236)5/8/1998 12:36:00 PM
From: Anthony Wong  Read Replies (2) | Respond to of 9523
 
Pfizer Inc. Maintained 'Outperform' at Schroder & Co

Bloomberg News
May 8, 1998, 7:10 a.m. PT

Princeton, New Jersey, May 8 (Bloomberg) -- Pfizer Inc. (PFE US)
was maintained ''outperform'' by analyst Jami Rubin at Schroder & Co.
The 12-month target price is $120.00 per share. Rubin raised her 1999 est. to
$2 .60 from $2.50 per share.

-- Andrew Bekoff in the Princeton, New Jersey newsroom, (609)279-3652


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News